Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03745248
Other study ID # AAAR5381
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 14, 2018
Est. completion date October 14, 2019

Study information

Verified date December 2019
Source Columbia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The first aim is to show aerobic training improves degenerative cerebellar patients functionally

The second aim is to compare the effects of balance and aerobic training on degenerative cerebellar disease.


Description:

Individuals with degenerative cerebellar disease (DCD) exhibit gradual loss of coordination resulting in impaired balance, gait deviations, and severe, progressive disability. With no available disease-modifying medications, balance training is the primary treatment option to improve motor skills and functional performance.

Aerobic training, on the other hand, may modify DCD progression as evident from animal data. Compared to sedentary controls, aerobically trained DCD rats have enhanced lifespan, motor function, and cerebellar Purkinje cell survival. Numerous animal studies also document that aerobic training has a direct, favorable effect on the brain that includes production of neurotrophic hormones, enhancement of neuroplasticity mechanisms, and protection from neurotoxins.

The effects of aerobic training in humans with DCD are relatively unknown, despite these encouraging animal data. A single study to date has evaluated the benefits of aerobic exercise on DCD in humans, and this was a secondary outcome of the study. Although participants performed limited aerobic training during the study, modest functional benefits were still detected.

The main objective of this project will be to compare the benefits of aerobic versus balance training in DCD. The investigators hypothesize that both aerobic and balance training will improve function in DCD subjects, but that the mechanisms in which these improvements occur differ.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date October 14, 2019
Est. primary completion date June 9, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosed with spinocerebellar ataxia

- Cerebellar atrophy on MRI

- Prevalence of ataxia on clinical exam

- Ability to safely ride a stationary exercise bike

Exclusion Criteria:

- Other neurologic conditions

- Heart disease

- Cognitive impairment

- Medical instability

Study Design


Intervention

Behavioral:
Aerobic training
Aerobic training on stationary bicycle for 30 minutes a day, 5 days a week for 1 month
Balance Training
Standard of care

Locations

Country Name City State
United States Columbia University/New York Presbyterian New York New York

Sponsors (1)

Lead Sponsor Collaborator
Columbia University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in SARA score Ataxia severity will be measured using the Scale for the Assessment and Rating of Ataxia (SARA).SARA evaluates the degree of ataxia by measuring gait, stance, sitting balance, speech, finger-chase test, nose-finger test, fast alternating movements, and heel-shin test. 1 month
Secondary Change in gait speed For the walking assessment, participants will walk as fast as possible on a 10-meter runway six times, and the investigators will average the times of trials 3-6 to determine gait speed expressed in meters/second. 1 month
Secondary Change in static balance Static standing balance will be assessed by measuring postural sway during two, one-minute trials. Participants will stand with arms crossed over their chest and feet shoulder-width apart under two conditions: eyes open and eyes closed. Data will be collected using Bertec's dual split-belt treadmill (Bertec, Columbus, OH) embedded with force plates. Balance deficits will be calculated as the magnitude of postural sway (sway amplitude) using custom Nexus and Bodybuilder software (Vicon, Denver, CO). 1 month
See also
  Status Clinical Trial Phase
Completed NCT03722212 - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test N/A
Completed NCT05563402 - "Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis" N/A
Terminated NCT03645265 - Rhythmic Entrainment in Bilingual Speakers With Dysarthria N/A
Completed NCT05585541 - Teleassessment in Ataxic Multiple Sclerosis
Recruiting NCT05125666 - Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection Phase 2
Recruiting NCT03881930 - Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy N/A
Completed NCT00950196 - Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia Phase 4
Completed NCT04183647 - Investigation of Acute Effects of Local Vibration and Whole-Body Vibration Applications N/A
Completed NCT04099914 - Validation of a Clinical Algorithm for the Diagnosis of Recessive Ataxias
Recruiting NCT03945682 - The ASsessment and Physiotherapy managEment of Ataxia in Children Following Surgical Resection of Posterior Fossa Tumour N/A
Completed NCT01428544 - Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) N/A
Completed NCT00001324 - PET Scan to Study Brain Control of Human Movement
Recruiting NCT05486806 - Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders
Completed NCT06001424 - Effect of Life Kinetik Training on Lower Limb Coordination in Ataxic Patients N/A
Completed NCT00244361 - Effectiveness of Rituximab in Pediatric OMS Patients. Phase 1/Phase 2
Completed NCT00692861 - Autoimmunity in Neurologic Complications of Celiac Disease
Recruiting NCT05885282 - Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization Exercises N/A
Recruiting NCT02841553 - Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Completed NCT05621200 - Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia N/A
Completed NCT02829268 - A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome Phase 1/Phase 2